CiVi Biopharma, Inc. Employee Directory
Biotechnology ResearchMaryland, United States2-10 Employees
CiVi Biopharma, Inc. is a US-based, privately held biotechnology company founded in 2016 and located in Chevy Chase, Maryland. Its research and development efforts focus on creating therapies for cardiovascular and metabolic diseases, with a pipeline that includes CiVi007, a long-acting antisense molecule targeting PCSK9 for hypercholesterolemia and cardiovascular disease prevention, alongside other clinical-stage programs addressing severe liver diseases. The company operates within the biotechnology research sector, aiming to advance novel treatments through its early-to-clinical development activities. CiVi Biopharma positions itself as a specialized, small-scale biopharma entity pursuing therapies for cardiovascular, metabolic, and related conditions. The organization leverages its location near the Washington, D.C. area to conduct its R&D activities and advance its pipeline within the clinical development landscape.